abstract |
The invention provides compounds of formula (I): wherein R 1 , R 2 , A, A 1 and B are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors. |